Document Classification

Section Type: RESULTS

Text: Patients treated with Montelukast improved their nasal symptoms (Delta HRQL-score 0. 58 + / - 0. 94, P < 0. 01), practical problems (Delta HRQL-score 0. 42 + / - 0. 71, P < 0. 05), headaches (Delta HRQL-score 0. 38 + / - 0. 56, P < 0. 05), non-nasal symptoms (Delta HRQL-score 0. 35 + / - 0. 92, P < 0. 05), sleep (Delta HRQL-score 0. 26 + / - 0. 71) and emotional problems (Delta HRQL-score 0. 18 + / - 0. 75).